CLARISCAN 0.5 mmol/ml, solution for injection bottle, 10 ml
Active ingredients: Gadoteric acid, Gadoterate meglumine
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CLARISCAN 0,5 mmol/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- GE HEALTHCARE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 6 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61696661CIP73009190CIP133400930091906Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GADOTÉRATE DE MÉGLUMINEsolution | — | SA |
| ACIDE GADOTÉRIQUEsolution | 279,3 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
- 10 bottles of 5 mlCommercialized according to BDPM
- 10 bottles of 10 mlCommercialized according to BDPM
- 10 bottles of 15 mlCommercialized according to BDPM
- 10 bottles of 20 mlCommercialized according to BDPM
- 10 bottles of 50 mlCommercialized according to BDPM
- bottle, 15 mlCommercialized according to BDPM
- bottle, 20 mlCommercialized according to BDPM
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.